Summary. Bovine luteal cells can utilize low density lipoprotein (LDL) or high density lipoprotein (HDL) as a source of cholesterol for steroidogenesis, and administration of PGF-2\g=a\ in vitro suppresses lipoprotein utilization. The objective of this study was to examine the mechanism by which PGF-2\g=a\ exerts this effect. Cultured bovine luteal cells received 0\m=.\25\g=m\Ci[14C]acetate/ml, to assess rates of de-novo sterol and steroid synthesis, with or without lipoproteins. Both LDL and HDL enhanced progesterone production (P < 0\m=.\01), but caused a significant reduction in the amount of radioactivity in the cholesterol fraction. PGF-2\g=a\ treatment inhibited the increase in lipoprotein-induced progesterone synthesis (P < 0\m=.\01), but did not prevent the reduction in de-novo cholesterol synthesis brought about by LDL or HDL. PGF-2\g=a\ alone reduced cholesterol synthesis (P < 0\m=.\01), but it was not as effective as either LDL or HDL. Both lipoproteins and PGF-2\g=a\ also decreased the amount of radioactivity in the progesterone fraction (P < 0\m=.\01), and the effect of PGF-2\g=a\ was similar to that of the lipoproteins. It is concluded that lipoproteins can enhance progesterone production and also suppress de-novo cholesterol synthesis in bovine luteal cells, but only the former effect of lipoproteins is inhibited by PGF-2\g=a\. Therefore, it is suggested that PGF-2\g=a\ allows entry of lipoprotein cholesterol into the cell, but prevents utilization for steroidogenesis. In addition, PGF-2\g=a\ alone can suppress cholesterol synthesis, as well as decrease conversion of cholesterol to progesterone.
Introduction
It is now generally accepted that steroidogenic tissues can derive cholesterol from circulating lipo¬ proteins, and this may provide the major source of substrate for steroid synthesis. Bovine luteal cells in vitro can utilize either low-density lipoprotein (LDL) or high-density lipoprotein (HDL) as a source of cholesterol for increased progesterone production (Pate & Condon, 1982;  O'Shaughnessy & Wathes, 1985) . Blood-borne cholesterol appears to be physiologically important for luteal func¬ tion in the cow, because elevated serum cholesterol values result in increased progesterone concen¬ trations during the luteal phase (Talavera et ai, 1985) . Circulating cholesterol is probably the preferred substrate, as opposed to de-novo synthesis of cholesterol, in many species (see review by Gwynne & Strauss, 1982; Swann & Bruce, 1986) .
Cellular cholesterol synthesis, esterification and hydrolysis are adjusted in accordance with a balance between the metabolic needs of the cell and the supply of exogenous cholesterol. In many tissues, when lipoprotein-carried cholesterol is sufficient to meet the needs of the cell, the ratelimiting enzyme in cholesterol synthesis, 3-hydroxy-3-methylglutaryl coenzyme A (HMG Co A), reductase, is suppressed (Schüler et ai, 1981; Savion et ai, 1982) . In bovine luteal cells, cholesterol synthesized de novo is apparently unnecessary for progesterone synthesis when lipoproteins are present (O'Shaughnessy & Wathes, 1985) , although there is no direct evidence that lipoproteins can regulate cholesterol synthesis in these cells.
A recent study from this laboratory provided evidence that prostaglandin (PG) F-2ct can inhibit utilization of lipoproteins for progesterone synthesis (Pate & Nephew, 1988 (Pate & Condon, 1982; Pate & Nephew, 1988) . All cells were cultured in serum-free Ham's F-12 culture medium (with 24 min-Hepes buffer) containing penicillin (100 U/ml), streptomycin (100 pg/ml) (Pen-Strep, K.C. Biological, Lenexa, KS, USA), gentamicin (20 ng/ml, Grand Island Biological, Grand Island, NY), and supplemented with insulin (5 pg/ml), transferrin (5 pg/ml), and selenium (5 ng/ml) (ITS premix; Collaborative Research Inc., Lexington, MA, USA). Numbers of viable cells were quantified throughout the culture period as previously described (Pate & Nephew, 1988) .
Lipoprotein isolation. Lipoproteins were prepared from normal bovine serum obtained from blood collected from 5 non-lactating dairy cows. LDL (density 1 006-1 063g/ml) and HDL (density 1063-I-210g/ml) were prepared by differential ultracentrifugation using KBr for density adjustment (Havel et a!, 1955 (Schuler et a!, 1979) .
At the end of the 24 h exposure to [14C]acetate and lipoprotein, 1 ml medium from each flask was removed and frozen for assay of progesterone. The remaining medium was extracted twice with 5 ml anhydrous ether. The cell monolayers were rinsed with phosphate-buffered saline (pH 7-4), drained, and extracted with 5 ml hexane:isopropanol (3:2, v/v). The hexane:isopropanol and ether extracts were combined, dried under air at 37°C, and stored at -20°C, until further analysis.
For thin-layer chromatography, samples were reconstituted in benzene:ethanol (9:1, v/v) and applied to Silica Gel GF254 t.l.c. plates (Fisher Scientific, Cincinnati, OH, USA). One-dimensional chromatography was performed in benzene:methylene chloride (1:1, v/v) followed by hexane:ethyl acetate (5:2, v/v). Progesterone and cholesterol spots, as determined by migration of standards, were eluted from the silica gel with methanol (3 ml, twice). This method has been previously used to isolate various classes of lipids (Skipski & Barclay, 1969) and effectively separates cholesterol and progesterone in incubation media from bovine luteal tissue (Armstrong & Black, 1966; Condon & Black, 1976 days in the presence of 0 or 10 ng PGF-2ct/ml. All cultures also received 10 ng LH/ml. The effect of PGF-2a on total progesterone production by these cells is depicted in Fig. 3 . As expected, PGF-2a inhibited LH-stimulated progesterone (control bars), and also suppressed the elevation in steroido¬ genesis brought about by the presence of LDL or HDL. PGF-2ot therefore prevented complete utilization of the lipoproteins for steroid synthesis.
The rate of de-novo synthesis of cholesterol in these cultures is represented in Fig. 4 calculated for each of these samples (data not shown), and these data confirmed that the effect of the lipoproteins was not simply due to a dilution of the total pool.
Discussion
The stimulation of progesterone synthesis by the presence of LDL or HDL is consistent with earlier reports using cultured bovine luteal cells (Pate & Condon, 1982; O'Shaughnessy & Wathes, 1985) or cultured granulosa cells from the cow (Savion et ai, 1982) or rat (Schuler et ai, 1979; Schreiber et ai, 1980) . Furthermore, it can be seen from the results that the availability of lipoproteincholesterol can regulate de-novo sterol synthesis in bovine luteal cells, as in fibroblasts (Brown & Goldstein, 1980) , adrenal cells (Balasubramaniam et ai, 1977) , and granulosa cells (Schuler et ai, 1979 (Schuler et ai, , 1981 Tureck & Strauss, 1982) .
In both experiments presented here, the assumption was made that incorporation of [14C]acetate into cholesterol represented de-novo sterol synthesis. Since the specific activity of [14C]acetate was not determined, the exact rate of cholesterol synthesis could not be calculated. However, relative changes in rates of sterol metabolism can be detected by this method (Schuler et ai, 1979) , which has been extensively used for this purpose (Rosenblum et ai, 1981; Baranao & Hammond, 1985; Gwynne et ai, 1985) . Also, it is likely that the [14C]acetate entered the cellular pool of acetyl CoA and was converted to products other than cholesterol and progesterone, such as fatty acids, but it has been previously shown that lipoproteins do not affect this process (Rosenblum et al., 1981) . The finding that de-novo cholesterol synthesis is suppressed in the presence of LDL or HDL in bovine luteal cells is further supported by the large body of evidence which indicates that lipoproteins reduce the activity of HMG CoA reducíase (Simpson et ai, 1978; Brown & Goldstein, 1980; Schuler et ai, 1981; Savion et ai, 1982) . It was important, however, to confirm the existence of this regulation in bovine luteal cells, since some steroidogenic cell types rely heavily on newly synthesized cholesterol even in the presence of lipoproteins (Carr et ai, 1980) .
It has been previously determined in this laboratory that exposure of luteal cells in culture to prostaglandin F-2a will result in a suppression of lipoprotein-enhanced progesterone production (Pate & Nephew, 1988 Rajkumar et ai (1985) reported that HDL binding to rat luteal membranes is not decreased after an in-vivo injection of PGF-2a. During PGF-2a-induced luteolysis, the corpora lutea of ewes and cows accumulate substantial stores of lipid (Umo, 1975; Heath et ai, 1983) , implying that the uptake of cholesterol is unimpaired. Therefore, it seems possible that PGF-2a allows binding and internalization of lipoproteins, but utilization of the cholesterol for steroidogenesis is abrogated. This may be similar to the situation in gonadotrophin-desensitized luteal cells, in which lipoprotein uptake is increased but the cholesterol is not metabolized to progesterone (Rajendran et ai, 1985) . The delivery of cholesterol to luteal cells by LDL and HDL occurs by two distinct mechanisms, and it appears that, unlike LDL, the HDL molecule is not internalized (Paavola et ai, 1985; Gwynne et ai, 1985) . PGF-2rx could inhibit utilization of LDL and HDL in a similar manner if the inhibition was imposed subsequent to cholesterol entry into the cell.
The rate-limiting step of steroid synthesis is the cleavage of the cholesterol side chain, brought about by the action of the mitochondrial cytochrome P-450 enzyme complex. It is possible that PGF-2ct inhibits this important step in the conversion of cholesterol to progestagen, thereby preventing the utilization of lipoprotein-derived cholesterol. Alternatively, PGF-2a could prohibit the transport of cholesterol to the mitochondria, thereby rendering it unavailable for side-chain cleavage. Microtubules are involved in the transport and use of LDL in cultured rat luteal cells (Rajan & Menon, 1985) and the cytoskeleton is involved in the transport of cholesterol to the mitochondria (Hall, 1985) . One potential action of PGF-2a could be to disrupt the cytoskeletal network, thus preventing movement of accumulated cholesterol to the mitochondria. However, at this time further investigation is required to determine whether PGF-2a can directly affect cytoskeletal elements.
The results of this study also represent the first report that PGF-2a can directly decrease de-novo cholesterol synthesis. Although the mechanism of this action is unknown, this could occur in response to cytoskeletal disruption, which results in a decline in the activity of HMG-CoA reducíase (Volpe, 1979) . By whatever mechanism, the direct suppression of cholesterol synthesis by as 
